Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Eye Drops and Lubricants Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Eye Drops and Lubricants Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Eye Drops and Lubricants Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Eye Drops and Lubricants Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 25 Jun 2021
  • Report ID: HLT 00224
  • Pages: 179
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

The global eye drops and lubricants market is estimated to grow at a CAGR of 5.6% during the forecast period. Eye drops and lubricants are used to treat people suffering from various eye problems, such as eye dryness, swelling, redness, infection (pink eye), allergies, itching, soreness, and others. Eye infections such as bacterial keratitis and conjunctivitis are chronic infections treated with the help of antibiotics therapy. In addition to this, eye and vision problems also cause due to imbalance in hormone levels, as hormones regulate essential body functions, and changes in them can affect the eyes and vision. The innovation of advanced prospect molecules and novel combination therapies is expected to propel the growth of the eye drops and lubricants market in the forecast period.

Top Driver: Rising Incidence and Emergence of Drug Discovery

The rise in the incidence of ophthalmic disorders across the world, changes in the demographics across the globe, and the emergence of drug discovery and development for the treatment of eye disorder and diseases are the factors that are propelling the growth of the global eye drops and lubricants market. On the other hand, extended duration required for the approval of eye drops and lubricants and the risk of associated adverse effects hinders the market growth. However, an increase in investment by manufacturers in the emerging economies and rapid initiatives to reduce the burden of glaucoma all over the world are estimated to offer lucrative opportunities for market expansion.

The Artificial Tears Market is Estimated to Grow In the Coming Years

The eye drops and lubricants market is segmented into antibiotics, hormones, artificial tears, and others based on type. The artificial tear segment accounted for the highest revenue and is expected to continue its dominance during the forecast period due to the surge in demand for the product, rise in the number of dry eye syndrome worldwide. In addition to this, easy accessibility and availability of lubricating eye drop further fuel the market growth. Based on the application, the market has been segmented into eye disease, eye care, and others

  Increase in the Prevalence of Glaucoma, Cataract, and Other Ophthalmic Disorders to Benefit North America Market

Based on the region, the eye drops and lubricants market is segmented into North America, Europe, Asia-Pacific, and SAMEA. North America accounted for the largest market share in the eye drops and lubricants market and is expected to continue the trend throughout the forecast period due to an increase in the prevalence of glaucoma, cataract, and other ophthalmic disorders. However, Asia-Pacific is expected to create lucrative opportunities with maximum growth potential, due to the rapid development in healthcare infrastructure, increased healthcare initiatives by its government, and rise in the incidence of ophthalmic disorders.

 

Players to Focus on Eye Drops and Lubricant Market

The global eye drops and lubricants market is estimated to stay fragmented in the forecast period owing to the possible new entrants. The key players operating in the market are Novartis International AG (Alcon Inc.), Akorn Consumer Health (TheraTears), Allergan plc, ROHTO Pharmaceutical Co., Ltd., Johnson & Johnson, Pfizer, Inc., Similasan Corporation USA, Sager Pharma Kft., Prestige Consumer Healthcare, Inc., and Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated).

Novartis: In May 9, 2019, Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® 5% worldwide. Xiidra is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The transaction is estimated to bolster the Novartis front-of-the-eye portfolio and ophthalmic leadership.

Atlas Nanotech: In Nov. 14, 2019, Atlas Nanotech licensed their proprietary nanotechnology vitamin a (retinol) based crystalline eye drops known under the trade name “NANO CLEAR A”, to the leading eye drop manufactures, by licensing Nano Clear A to existing top tier eye drop manufactures it will allow the product to be widely used at a rapid pace.

Scope of the Report

By Type

  • Antibiotics
  • Hormones
  • Artificial Tears
  • Others

By Application

  • Eye disease
  • Eye care
  • Others

 By End-User

  • Energy
  • Auto Mobiles
  • Manufacturing
  • Household Appliances
  • Other

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report